Empirical prior distributions for Bayesian meta-analyses of binary and time to event outcomes
Franti\v{s}ek Barto\v{s}, Willem M. Otte, Quentin F. Gronau, Bram, Timmers, Alexander Ly, Eric-Jan Wagenmakers

TL;DR
This paper develops empirical prior distributions for Bayesian meta-analyses of binary and time-to-event outcomes using a large clinical trial database, enabling more informed and discipline-wide Bayesian analyses.
Contribution
It introduces empirically derived prior distributions for treatment effects and heterogeneity, validated on extensive real-world data, and demonstrates their application in Bayesian meta-analysis.
Findings
Binary outcomes meta-analyses favor no effect or heterogeneity
Time-to-event outcomes favor presence of effect and heterogeneity
Proposed priors are applicable across medical subdisciplines
Abstract
Bayesian model-averaged meta-analysis allows quantification of evidence for both treatment effectiveness and across-study heterogeneity . We use the Cochrane Database of Systematic Reviews to develop discipline-wide empirical prior distributions for and for meta-analyses of binary and time-to-event clinical trial outcomes. First, we use 50% of the database to estimate parameters of different required parametric families. Second, we use the remaining 50% of the database to select the best-performing parametric families and explore essential assumptions about the presence or absence of the treatment effectiveness and across-study heterogeneity in real data. We find that most meta-analyses of binary outcomes are more consistent with the absence of the meta-analytic effect or heterogeneity while meta-analyses of time-to-event outcomes are more consistent with the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMeta-analysis and systematic reviews · Statistical Methods in Clinical Trials · Health Systems, Economic Evaluations, Quality of Life
